| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |